Table 6.
Multivariate Model: Serious Complications
| Covariate | OR (95% CI) | p-value |
|---|---|---|
| ASA class * | 1.807 (1.126-2.898) | 0.014 |
| Age | 0.998 (0.978-1.018) | 0.833 |
| Stent Type | ||
| NS vs SEMS | 1.608 (0.761-3.398) | 0.213 |
| PES vs SEMS | 1.457 (0.666-3.186) | 0.346 |
| Pathology and neoadjuvant therapy ** | ||
| Adenocarcinoma with neoadjuvant therapy vs adenocarcinoma without neoadjuvant therapy | 1.291 (0.575-2.899) | 0.535 |
| Benign vs adenocarcinoma without neoadjuvant therapy | 1.424 (0.856-2.369) | 0.174 |
*
Class 3 or 4 vs class 1 or 2
**
Only patients with adenocarcinoma were eligible for neoadjuvant therapy